Co-treating mesenchymal stem cells with IL-1β and TNF-α increases VCAM-1 expression and improves post-ischemic myocardial function

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 792-798

  Wang, Chun Miao ^a   Guo, Zeng ^a   Xie, Yang Jing ^a   Hao, Yu Yu ^b   Sun, Ji Min ^a   Gu, Jian ^b   Wang, Ai Ling ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b First Hefei People's Hospital   (China)

Author keywords

Inflammatory cytokine; Mesenchymal stem cells; Myocardial ischemia; Vascular cell adhesion molecule 1

Indexed keywords

CELL SURFACE MARKER; CELL THERAPY AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; IMMUNOSTIMULATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; RAT MODEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ECHOCARDIOGRAPHY; GENETICS; HEART; HEART MUSCLE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL ADHESION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; HEART; INTERLEUKIN-1BETA; MALE; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84903266491     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2236     Document Type: Article

References (38)

1. Schulman IH and Hare JM: Key developments in stem cell therapy in cardiology. Regen Med 7 (6 Suppl): 17-24, 2012.
2. Luo Y, Wang Y, Poynter JA, et al: Pretreating mesenchymal stem cells with interleukin-1β and transforming growth factor-β synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery 151: 353-363, 2012.
3. Zheng Z, Leng Y, Zhou C, Ma Z, Zhong Z, Shi XM and Zhang W: Effects of matrix metalloproteinase-1 on the myogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. Biochem Biophys Res Commun 428: 309-314, 2012.
4. Herrmann JL, Weil BR, Abarbanell AM, Wang Y, Poynter JA, Manukyan MC and Meldrum DR: IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock 35: 512-516, 2011.
5. Cui X, Wang H, Guo H, Wang C, Ao H, Liu X and Tan YZ: Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med 220: 139-147, 2010.
6. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K and Murry CE: Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921, 2001. (Pubitemid 32545326)
7. Nian M, Lee P, Khaper N and Liu P: Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553, 2004. (Pubitemid 38856961)
8. Carrero R, Cerrada I, Lledó E, et al: IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. Stem Cell Rev 8: 905-916, 2012.
9. Fan H, Zhao G, Liu L, et al: Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol 9: 473-481, 2012.
10. Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB and Kim JH: Tumor necrosis factor-α-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol 131: 1559-1567, 2011.
11. Kim YS, Park HJ, Hong MH, et al: TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Front Biosci (Landmark Ed) 14: 2845-2856, 2009.
12. Herrmann JL, Abarbanell AM, Weil BR, et al: Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function. Am J Physiol Regul Integr Comp Physiol 299: R371-R378, 2010.
13. Deten A, Volz HC, Briest W and Zimmer HG: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55: 329-340, 2002. (Pubitemid 34775283)
14. Chute JP: Stem cell homing. Curr Opin Hematol 13: 399-406, 2006.
15. Segers VF, Van Riet I, Andries LJ, et al: Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 290: H1370-H1377, 2006.
16. Balzer EM and Konstantopoulos K: Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med 4: 171-181, 2012.
17. Bonig H, Priestley GV and Papayannopoulou T: Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood 107: 79-86, 2006. (Pubitemid 43053527)
18. Hu Y, Cheng P, Xue YX and Liu YH: Glioma cells promote the expression of vascular cell adhesion molecule-1 on bone marrow-derived mesenchymal stem cells: a possible mechanism for their tropism toward gliomas. J Mol Neurosci 48: 127-135, 2012.
19. Wang Y, Crisostomo PR, Wang M, Markel TA, Novotny NM and Meldrum DR: TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 295: R1115-R1123, 2008.
20. Herrmann JL, Abarbanell AM, Wang Y, Weil BR, Poynter JA, Manukyan MC and Meldrum DR: Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protection. Ann Thorac Surg 92: 1719-1725, 2011.
21. Böcker W, Docheva D, Prall WC, et al: IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med (Berl) 86: 1183-1192, 2008.
22. Tropel P, Noël D, Platet N, Legrand P, Benabid AL and Berger F: Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295: 395-406, 2004. (Pubitemid 38490494)
23. Wang A, Shen F, Lang Y and Wang J: Marrow-derived MSCs and atorvastatin improve cardiac function in rat model of AMI. Int J Cardiol 150: 28-32, 2011.
24. Ren G, Roberts AI and Shi Y: Adhesion molecules: key players in mesenchymal stem cell-mediated immunosuppression. Cell Adh Migr 5: 20-22, 2011.
25. Kim HJ, Lee SI, Lee DH, Smith D, Jo H, Schellhorn HE and Boo YC: Ascorbic acid synthesis due to L-gulono-1,4-lactone oxidase expression enhances NO production in endothelial cells. Biochem Biophys Res Commun 345: 1657-1662, 2006. (Pubitemid 43833444)
26. Niagara MI, Haider HKh, Jiang S and Ashraf M: Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545-555, 2007. (Pubitemid 46673264)
27. Mias C, Lairez O, Trouche E, et al: Mensenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiacventricular fibrosis after myocardial infarction. Stem Cells 27: 2734-2743, 2009.
28. Xiao Q, Wang SK, Tian H, et al: TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem Biophys 62: 409-414, 2012.
29. Thankamony SP and Sackstein R: Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci USA 108: 2258-2263, 2011.
30. Hyun YM, Chung HL, McGrath JL, Waugh RE and Kim M: Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1. J Immunol 183: 359-369, 2009.
31. Yilmaz G and Granger DN: Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 12: 193-204, 2010.
32. Armiñán A, Gandía C, García-Verdugo JM, et al: Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol 55: 2244-2253, 2010.
33. Kawada H, Fujita J, Kinjo K, et al: Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581-3587, 2004. (Pubitemid 39564430)
34. Horwitz EM and Prather WR: Cytokines as the major mechanism of mesenchymal stem cell clinical activity: expanding the spectrum of cell therapy. Isr Med Assoc J 11: 209-211, 2009.
35. Shake JG, Gruber PJ, Baumgartner WA, et al: Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73: 1919-1925, 2002.
36. Mangi AA, Noiseux N, Kong D, et al: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201, 2003. (Pubitemid 37173705)
37. Tsoyi K, Jang HJ, Nizamutdinova IT, et al: PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells. Atherosclerosis 213: 115-121, 2010.
38. Ward SG, Westwick J and Harris S: Sat-Nav for T cells: role of PI3K isoforms and lipid phosphatases in migration of T lymphocytes. Immunol Lett 138: 15-18, 2011.